Subtitle: The Bronchodilators Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Bronchodilators Market: Drivers and Challenges
According to the Centers for Disease and Control of Infection, in 2014 number of adults who had asthma was 17.7 million. It seen more in female over male, and caused 3,651 number of deaths. According World Health Organization, in 2012 over 3 million people died due to COPD, which is equal to 6% of all deaths globally that year. These death mostly occurred in low- and middle-income countries, and the risk factors included air pollution caused by cooking and heating, outdoor air pollution, pollution due to dust and chemicals (vapor’s, irritants and fumes), and lower respiratory infections during childhood. Above mentioned are some of the leading causes of preventable death. Moreover due to government initiatives and rising healthcare expenditure it is expected to fuel the bronchodilators market over the forecast period. Also factors such as rising adoption of these products, and patient education program that are conducted by government and companies for creating the awareness among the general population is likely to drive the growth of bronchodilators market over forecast period. However Bronchodilators market has some restraints such as low awareness for these products and cost of treatment is expected to hinder the growth of the bronchodilators market.
Rise in the incidence of COPD, asthma is expected to boost the bronchodilators market over the forecast period. In addition rising awareness among general population and physician adopting these products and prescribing these drugs is expected to drive the bronchodilators market during the forecast period.
Bronchodilators Market: Regional Overview
Geographically the bronchodilators market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.
North America followed by Europe is dominating the bronchodilators market as high incidence of COPD and asthma cases. Apart from these combination therapies are becoming more popular and preferred choice of treatment in the U.S. as they have better efficacy. In Asia Pacific region the bronchodilators market is expected to deliver significant growth as China is the world’s largest tobacco producer and accounts for 42% globally for cigarette production. According to WHO, majority of the world’s smoking population is present in China, this is expected to boost the demand for bronchodilators products over the forecast period.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12241
Bronchodilators Market: Key Players
Some of the major companies in the bronchodilators market are Ache Laboratorios Farmaceuticos, Aquinox Pharmaceuticals, BioMarck Pharmaceuticals, F. Hoffmann-La Roche, Gilead Sciences, Innoviva, MediciNova, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline plc, Merck & Co., Inc., Novartis Ag, and others
Browse Full Report summary and to request sample report and table of content@ http://www.persistencemarketresearch.com/market-research/bronchodilators-market.asp
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353